drugset / Trial / NCT00407797
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the clinical improvement by partial seizures reduction, safety and tolerability of subjects having partial epilepsy related to the adjunction of pregabalin BID (75 to 300mg day titration, BID) to existing standard AED (Antiepileptic drugs).
Timeline
- Start
- 2007-03
- Primary completion
- 2009-08
- Completion
- 2009-08
Outcome
Met primary endpoint
registry analysis (unspecified test); Pregabalin; p <.0001; t-test, 2 sided NCT00407797 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 150 mg | — |
| Subject | Pregabalin | Small molecule | 300 mg | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |